Ewa Dembowski, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 199 W Rand Rd Ste 203, Mount Prospect, IL 60056 Phone: 847-618-0326 Fax: 708-618-5459 |
News Archive
The National Oceanic and Atmospheric Administration and the U.S. Food and Drug Administration are taking additional steps to enhance inspection measures designed to ensure that seafood from the Gulf of Mexico reaching America's tables is safe to eat.
Physicians now have access to real time radiology services virtually anywhere, anytime. The new Virtual Viewbox- (patent pending) is a portable interface system that delivers images, electronic medical records (EMR), and specialist consultation to physicians using any internet-ready device.
A study, led by cardiologist, Dr. Franklin Zimmerman of Columbia University, will use an ambulatory blood pressure monitor (ABPM) to determine whether cheering for your favorite baseball team is hazardous to your health.
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.
› Verified 3 days ago